Persistence Of A T(11;14)-Positive Clone In A Patient With Mantle Cell Lymphoma For 20years

CLINICAL CASE REPORTS(2017)

引用 0|浏览6
暂无评分
摘要
We report here a patient with extremely indolent mantle cell lymphoma (MCL) who had progressed and required immunochemotherapy 20 years after diagnostic splenectomy. Non-nodal, indolent MCL patients may progress after such an extraordinary long indolent phase, and we recommend lifelong follow up for such cases.
更多
查看译文
关键词
Cyclin D1, mantle cell lymphoma, somatic hypermutation analysis, Sox11, Splenectomy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要